Supplementary Files
Keywords
How to Cite
Abstract
Objective: To find out the association between electroencephalogram (EEG) and hepatic encephalopathy.
Methodology: This cross-sectional study included 100 patients (with the age of52.5±6.09years for males and 51.7 ± 6.10 years for females) of reported hepatic encephalopathy, visiting the medical department (indoor and OPD) at Federal Government Polyclinic Hospital, Islamabad. The study was conducted from January 2020 to May 2021. Patients who had known epileptic and structural brain lesions or strokes were excluded from the study. Statistical analysis was done using GraphPad Prism software. The significance of data (p-value or R2 value) was calculated through a two-tailed test or correlation coefficient.
Results: All the patients in hepatic encephalopathy grade IV reported abnormal EEG representing triphasic waves and flattening of EEG pattern. There was no correlation observed between age, gender and hepatic encephalopathy grades. However, a significant correlation (R2= 0.9032) was observed between serum ammonia levels and hepatic encephalopathy grades. Elevated serum ammonia levels depicted the severity of hepatic encephalopathy. Overall, the percentage of patients with abnormal EEG increased with increasing grade of hepatic encephalopathy. It was quite intriguing to note that EEG, being the common method to diagnose hepatic encephalopathy grades, is not dependent on patients’ socio-economic status.
Conclusion: Data concluded that serum ammonia levels are well associated with the progression of hepatic encephalopathy. Moreover, the EEG patter provides the appropriate information about the neurological abnormalities associated with the severity of hepatic encephalopathy. Hence, serum ammonia levels and EEG both should accurately be used as indicators for diagnosis and monitoring the response to the treatment of various grades of hepatic encephalopathy. Data warrant further investigations to get a better insight into hepatic encephalopathy's relationship with EEG patterns through the inclusion of molecular parameters.
References
Bass NMJCLD. A brief history of hepatic encephalopathy. 2021;18(Suppl 1):49. DOI: 10.1002/cld.1119
Ullah T, Iqbal M, Ali S, Ullah I, editors. Precipitating factors of hepatic encephalopathy in patients with liver cirrhosis. Med Forum; 2020. DOI: 10.7759/cureus.4363
Ridola L, Faccioli J, Nardelli S, Gioia S, Riggio OJJoTIM. Hepatic encephalopathy: diagnosis and management. 2020;8(4):210-9. DOI: 10.1111/liv.13752
Weissenborn KJD. Hepatic encephalopathy: definition, clinical grading and diagnostic principles. 2019;79(Suppl 1):5-9. DOI:10.1007/s40265-018-1018-z
Metwally MA, Biomy HA, Omar MZ, Sakr AIJEJoG, Hepatology. Critical flickering frequency test: a diagnostic tool for minimal hepatic encephalopathy. 2019;31(8):1030-4. DOI: 10.1097/MEG.0000000000001375
Mitra LG, Rajput G, Saluja V, Kumar GJJoC, Research T. EEG abnormality as a prognostic factor in cirrhotic patients with Grade III-IV hepatic encephalopathy requiring mechanical ventilation: A retrospective analysis. 2021;7(4):467. DOI.org/10.1186/s13054-022-04163-1
Manzhalii EG, Falalyeyeva TM, Moyseyenko VO, Weiskirchen R, Stremmel WJDD. Elevation of Autoantibodies to Cerebral Proteins in Hepatic Encephalopathy: Another Pathogenic Factor? 2022;40(2):232-8. DOI: 10.1159/000516412
Bloom PP, Tapper EB, Young VB, Lok ASJJoH. Microbiome therapeutics for hepatic encephalopathy. 2021;75(6):1452-64. DOI:https://doi.org/10.1016/j.jhep.2021.08.004
Butterworth RFJDiR. Ammonia removal by metabolic scavengers for the prevention and treatment of hepatic encephalopathy in cirrhosis. 2021;21(2):123-32. DOI: 10.1007/s40268-021-00345-4
Jain A, Sharma BC, Mahajan B, Srivastava S, Kumar A, Sachdeva S, et al. l‐Ornithine l‐aspartate in acute treatment of severe hepatic encephalopathy: a double‐blind randomized controlled trial. 2022;75(5):1194-203. DOI: 10.1002/hep.32255
Cheon SY, Jo D, Kim Y-K, Song JJOM, Longevity C. Long noncoding RNAs regulate hyperammonemia-induced neuronal damage in hepatic encephalopathy. 2022;2022. https://DOI.org/10.3390/biom13020396
Jalan R, Rose CFJJoh. Heretical thoughts into hepatic encephalopathy. 2022. DOI:https://doi.org/10.1016/j.jhep.2022.03.014
Rahwan M, Edwards JCJJoCN. Neuroimaging in Triphasic Waves. 2021;38(5):410-4. DOI: 10.1097/WNP.0000000000000778
Gelisse P, Crespel A, Gigli GL, Kaplan PWJCN. Stimulus-induced rhythmic or periodic intermittent discharges (SIRPIDs) in patients with triphasic waves and Creutzfeldt-Jakob disease. 2021;132(8):1757-69. DOI: 10.1016/j.clinph.2021.05.002
Ligtenstein S, Song J, Jin J, Sun H, Paixao L, Zafar S, et al. Do triphasic waves and nonconvulsive status epilepticus arise from similar mechanisms? A computational model. 2021;38(5):366-75. DOI: 10.1097/WNP.0000000000000719
Ryznar E, Wilcox DJP. Functional coma: Two case reports and a review of the literature. 2019;60(4):343-51. DOI: 10.1016/j.psym.2019.03.005
Rayi A, Mandalaneni K. Encephalopathic EEG Patterns. StatPearls [Internet]: StatPearls Publishing; 2022.
Willems LM, Trienekens F, Knake S, Beuchat I, Rosenow F, Schieffer B, et al. EEG patterns and their correlations with short-and long-term mortality in patients with hypoxic encephalopathy. 2021;132(11):2851-60. https://DOI.org/10.1016/j.clinph.2021.07.026
Tian X, Li FJM-MEMoSNIP. Application of Multimodal EEG in Coma Patients. 2022:161-75. DOI: https://doi.org/10.1007/978-981-16-4493-1_6
Tjepkema-Cloostermans MC, da Silva Lourenço C, Ruijter BJ, Tromp SC, Drost G, Kornips FH, et al. Outcome prediction in postanoxic coma with deep learning. 2019;47(10):1424-32. DOI: 10.1097/CCM.0000000000003854
Bohra A, Worland T, Hui S, Terbah R, Farrell A, Robertson MJWjog. Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care. 2020;26(18):2221. DOI: 10.3748/wjg.v26.i18.2221
Braekman E, Demarest S, Charafeddine R, Drieskens S, Berete F, Gisle L, et al. Unit response and costs in web versus face-to-face data collection: comparison of two cross-sectional health surveys. 2022;24(1):e26299. DOI: 10.2196/26299
Wang X, Cheng ZJC. Cross-sectional studies: strengths, weaknesses, and recommendations. 2020;158(1):S65-S71. DOI: https://doi.org/10.1016/j.chest.2020.03.012
Aneja A, Scott E, Kohli RJmjafi. Advances in management of end stage liver disease in children. 2021;77(2):129-37. DOI: 10.1016/j.mjafi.2021.03.001
Zamanian G, Partoazar A, Tavangar SM, Rashidian A, Mirzaei P, Niaz Q, et al. Effect of phosphatidylserine on cirrhosis-induced hepatic encephalopathy: Response to acute endotoxemia in cirrhotic rats. 2020;253:117606. DOI: 10.1016/j.lfs.2020.117606
Bajaj JS, Lauridsen M, Tapper EB, Duarte-Rojo A, Rahimi RS, Tandon P, et al. Important unresolved questions in the management of hepatic encephalopathy: An ISHEN consensus. 2020;115(7):989-1002. DOI: 10.14309/ajg.0000000000000603
Karanfilian BV, Park T, Senatore F, Rustgi VKJCiLD. Minimal hepatic encephalopathy. 2020;24(2):209-18.
Helzberg JH, Dai R, Muir AJ, Wilder J, Lee T-H, Martin JG, et al. Socioeconomic status is associated with the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation. 2021;32(7):950-60. e1. DOI: 10.1016/j.jvir.2020.11.022
Hopp AE, Dirks M, Petrusch C, Goldbecker A, Tryc AB, Barg‐Hock H, et al. Hepatic encephalopathy is reversible in the long term after liver transplantation. 2019;25(11):1661-72.
Cannon RM, Bolus DN, White JAJTAS. Irreversible electroporation as a bridge to liver transplantation. 2019;85(1):103-10. DOI: 10.1002/lt.25626
Hansen MKG, Kjærgaard K, Eriksen LL, Grønkjær LL, Mikkelsen ACD, Sandahl TD, et al. Psychometric methods for diagnosing and monitoring minimal hepatic encephalopathy—current validation level and practical use. 2022;37(3):589-605. DOI:https://doi.org/10.1007/s11011-022-00913-w
Rose CF, Amodio P, Bajaj JS, Dhiman RK, Montagnese S, Taylor-Robinson SD, et al. Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy. 2020;73(6):1526-47. DOI: 10.1016/j.jhep.2020.07.013
Freund B, Kotchetkov IS, Kaplan PWJJoCN. White Matter Disease—The True Source of Triphasic Waves? 2021;38(5):359-61. DOI: 10.1097/WNP.0000000000000745
Karanfilian BV, Cheung M, Dellatore P, Park T, Rustgi VKJCiLD. Laboratory abnormalities of hepatic encephalopathy. 2020;24(2):197-208. DOI: 10.1016/j.cld.2020.01.011
Biesbroek JM, Post MC, Hijlkema SH, Tromp SCJCR. An Elderly Woman With Recurrent Transient Loss of Consciousness Preceded by Hallucinatory Attacks. 2020;2(11):1824-7. DOI: 10.1016/j.jaccas.2020.04.055
Fasullo M, Rau P, Liu D-Q, Holzwanger E, Mathew JP, Guilarte-Walker Y, et al. Proton pump inhibitors increase the severity of hepatic encephalopathy in cirrhotic patients. 2019;11(6):522. DOI: 10.4254/wjh.v11.i6.522
Kaplan PW, Gélisse P, Sutter RJJoCN. An EEG voyage in search of triphasic waves—the sirens and corsairs on the encephalopathy/EEG horizon: a survey of triphasic waves. 2021;38(5):348-58. DOI: 10.1097/WNP.0000000000000725
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright (c) 2023 Anam Fatima, Faridullah Shah, Hareema Saeed Khan, Kashif Rauf, Asif Jalil, Muhammad Saleem Akhter